Conclusions: Men with low circulating free testosterone may have a lower risk of overall prostate cancer; this may be due to a direct biological effect, or detection bias. Further research is needed to explore the apparent differential association by tumour grade. Patient summary: In this study,...
MarkSoloway. (2009) Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?. Current Urology Reports 10 , 413-417 /Mark, Soloway. (2009) Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?. Current Urology Reports 10 , 413-417 /...
Garcia-Cruz E, Huguet J, Piqueras M, Marquez MP, Peri L, Izquierdo L, et al. Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy. World J Urol 2012;30:361--5.García-Cruz E, Huguet J, Piqueras M, Márquez MP, Peri L, ...
Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. Scientists from the University of Oxford conducted the largest anal...
Munich, Germany: A strategy of alternately flooding and starving the body of testosterone is producing good results in patients who have metastatic prostate cancer that is resistant to treatment by chemical or surgical castration, according to new findin
The high frequency of aggressive forms of PCa in Arab patients, despite the low levels of testosterone, indicates an increased sensitivity of Arab men to this steroid [5]. Prostate cancer is generally considered a complex disease and several genes underlie its onset, course, and severity. The ...
In subject area: Medicine and Dentistry Metastatic castrate-resistant prostate cancer (CRPC) is a disease state characterized by a testosterone level of less than 50 ng/dL, with 2 consecutive increases in prostate-specific antigen (PSA) with a PSA level of 2 ng/dL or more. ...
The patients with metastatic prostate cancer with low serum testosterone were in the high risk group of worse response to endocrine therapy. Additional therapy might be considered in those patients. 展开 关键词: prostate cancer testosterone prognosis ...
During the early stages of prostate cancer, you may have no symptoms. This might be because the prostate doesn’t increase in size with age, like it normally would, for those on estrogen or drugs that prevent androgens (male hormones) such as testosterone. ...
The following treatments may be used alone or together depending on the type and stage of prostate cancer you have:Hormone therapy is medicine used to decrease testosterone (male hormone) levels. Chemotherapy is medicine used to shrink or kill cancer cells. It is usually given IV. Radiation ...